Establishment Labs Holdings (ESTA) Sees Impressive Growth with 20% Market Share in US Breast Aesthetics

1 week ago 7

Soumya Eswaran

Wed, March 25, 2026 astatine 9:11 AM CDT 3 min read

Loomis Sayles, an concern absorption company, released its fourth-quarter 2025 capitalist missive for “Small Cap Growth Fund”. A transcript of the missive is disposable to download here. The tiny caps' net are reaccelerating successful 2025, arsenic the steadfast forecasted a twelvemonth ago. The marketplace besides experienced a low-quality rally wrong the small-cap space. Against this backdrop, the Small Cap Growth Fund underperformed the Russell 2000 Growth Index benchmark successful the quarter, returning 0.51% vs. 1.22% for the benchmark. Heading into 2026, determination are galore reasons to consciousness affirmative astir the economy, net growth, and the banal market. Please reappraisal the Fund’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Loomis Sayles Small Cap Growth Fund highlighted Establishment Labs Holdings Inc. (NASDAQ:ESTA) arsenic 1 of its starring contributors. Establishment Labs Holdings Inc. (NASDAQ:ESTA) is simply a aesculapian instrumentality institution focused connected bosom implants and different reconstructive integrative surgeries. On March 24, 2026, Establishment Labs Holdings Inc. (NASDAQ:ESTA) banal closed astatine $58.16 per share. Establishment Labs Holdings Inc. (NASDAQ:ESTA) delivered an -25.71% instrumentality successful the past month, and its shares gained 45.69% implicit the past 12 months. Establishment Labs Holdings Inc. (NASDAQ:ESTA) has a marketplace capitalization of $1.705 billion.

Loomis Sayles Small Cap Growth Fund stated the pursuing regarding Establishment Labs Holdings Inc. (NASDAQ:ESTA) successful its 4th fourth 2025 capitalist letter:

"Establishment Labs Holdings Inc. (NASDAQ:ESTA), Wave Life Sciences and MACOM Technology Solutions Holdings were the apical idiosyncratic contributors overall. Establishment Labs is simply a aesculapian instrumentality institution focused connected integrative surgery. The banal outperformed during the 4th arsenic the company’s income successful the US continued to turn with a projected 20% marketplace stock wrong bosom aesthetics."

Alternatives to Silicone Breast Implants and 5 Cheap Countries for Augmentation

Establishment Labs Holdings Inc. (NASDAQ:ESTA) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 39 hedge money portfolios held Establishment Labs Holdings Inc. (NASDAQ:ESTA) astatine the extremity of the 4th quarter, up from 29 successful the erstwhile quarter. In Q4 2025, Establishment Labs Holdings Inc. (NASDAQ:ESTA) reported gross of $64.6 cardinal an summation of 45.2% versus Q4 2024. While we admit the imaginable of Establishment Labs Holdings Inc. (NASDAQ:ESTA) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article